ADVERSE EFFECT VERSUS QUALITY CONTROL OF THE FUENZALIDA-PALACIOS ANTIRABIES VACCINE

We evaluated the components of the Fuenzalida-Palacios antirabies vaccine, which is till used in most developing countries in human immunization for treatment and prophylaxis. This vaccine is prepared from newborn mouse brains at 1% concentration. Even though the vaccine is considered to have a low...

Full description

Bibliographic Details
Published in:Revista do Instituto de Medicina Tropical de São Paulo
Main Author: Yeda L. NOGUEIRA
Format: Article in Journal/Newspaper
Language:English
Published: Universidade de São Paulo (USP) 1998
Subjects:
Adverse effect
Antirabies vaccine
Fuenzalida-Palacios
HDVC
Albumin
Crossed immunoelectrophoresis
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Barré
Ela
Fuenzalida
Online Access:https://doi.org/10.1590/S0036-46651998000500006
https://doaj.org/article/a9f498933fe045e8b76b82a7930c6cdb

Similar Items